Elevated hypercoagulability markers in hemoglobin SC disease. - Wikidata - awgldk - TriplyDB

Elevated hypercoagulability markers in hemoglobin SC disease.

Elevated hypercoagulability markers in hemoglobin SC disease.

http://www.wikidata.org/entity/Q35236050

about

Effects of hydroxyurea treatment for patients with hemoglobin SC disease.Tissue factor-dependent coagulation activation by heme: A thromboelastometry study.Effect of rivaroxaban on preventing deep vein thrombosis in aged diabetics with femoral neck fractures after hip replacement.Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.Venous Thromboembolism in Children with Cancer and Blood Disorders.Knowledge insufficient: the management of haemoglobin SC disease.Prasugrel hydrochloride for the treatment of sickle cell disease.Sickle cell retinopathy: improving care with a multidisciplinary approach.Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles.Stroke in a Child with Hemoglobin SC Disease: A Case Report Describing use of Hydroxyurea after Transfusion Therapy Melatonin Promotes Brain-Derived Neurotrophic Factor (BDNF) Expression and Anti-Apoptotic Effects in Neonatal Hemolytic Hyperbilirubinemia via a Phospholipase (PLC)-Mediated Mechanism.Computational imaging analysis of fibrin matrices with the inclusion of erythrocytes from homozygous SS blood reveals agglomerated and amorphous structures.Massive Ovarian Edema in a Girl with Hemoglobin SC Disease.

P2860

Q33427950-93E7E555-7C32-4E1E-B4A3-5B0DF8019B92 Q33596569-DF716916-4D95-48AE-B878-B9612B52F14E Q33820287-B09D3B0D-B64A-49F9-A726-3EA0829B2A98 Q36368068-E283CBFF-C162-428E-86BD-CF769D97FA6C Q37625771-F1A22D60-F425-41DC-B93F-9D874BEEB7E1 Q39041106-14453F50-29A5-4B21-8B70-99EAA465B53D Q39340714-618F5619-5BEA-444C-9EB3-504D5D6AC2F3 Q41634054-FB726B0F-45DC-426A-9072-564023FB6F95 Q41711843-76123F60-60DA-4D0C-9B76-5D2645EB5814 Q42292910-4818DE53-56EA-4999-AD59-75E30C6F40DF Q47160731-356D2000-1708-40BC-A256-9C955803503A Q50580182-BB03B765-C202-4C9A-987E-981C331F1FE8 Q55101003-DE2C143F-E88E-484E-A040-858AB7960946

P2860

Elevated hypercoagulability markers in hemoglobin SC disease.

http://www.wikidata.org/entity/Q35236050

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Elevated hypercoagulability markers in hemoglobin SC disease.

@ast

Elevated hypercoagulability markers in hemoglobin SC disease.

@en

type

label

Elevated hypercoagulability markers in hemoglobin SC disease.

@ast

Elevated hypercoagulability markers in hemoglobin SC disease.

@en

prefLabel

Elevated hypercoagulability markers in hemoglobin SC disease.

@ast

Elevated hypercoagulability markers in hemoglobin SC disease.

@en

P1433

Q35236050-009C9453-F778-4212-80A9-058F21015BC1

P1476

Q35236050-3E28C519-2A3F-4DFC-BDD0-F2BA1F280E3F

P2093

Q35236050-7628CA25-068C-400A-A831-B78063522D1F

Q35236050-85724C08-8C6C-4848-94EC-5BB0827111FB

Q35236050-9AA44457-EBD5-4572-8636-BF457857C7A3

Q35236050-B74E96E3-D794-4FD9-B481-780353FE4EEA

Q35236050-CA7757CC-C918-4019-8892-9EDFAE13A746

P2860

Q35236050-015B1F89-3D4E-41DD-8D5C-30C5B533332A

Q35236050-06885459-47AB-40D3-8900-94F9C7C962F7

Q35236050-15A9D552-7F6B-4AF9-B92C-D1F2CC14511A

Q35236050-41F80AFB-2DF0-4784-B298-98652AB958C8

Q35236050-4A908A05-C14E-4C93-8432-2FF425B703AE

Q35236050-544E8D9D-0285-4B18-B181-9D2F35F23930

Q35236050-57412BA8-73E6-4CF5-9184-315D782E667B

Q35236050-616C6804-87A7-491F-BD5F-C22D1B79A7B1

Q35236050-62D24787-54C4-438C-AA3E-41C4AC99EB7D

Q35236050-63450AED-53B9-45B0-9EAE-46BDC66E7933

P304

Q35236050-944A59CD-DAC2-4511-B5B3-FC666B4A08E3

P31

Q35236050-5C8370CE-A7B3-4A2E-AC41-E810B52623A5

P356

Q35236050-71F80D82-1283-4880-85BA-17D930D28CB2

P433

Q35236050-D12C0AC3-6298-4251-A5A2-4D4B57CC8719

P478

Q35236050-22252C71-D132-4F5D-8442-04F9428B3AD1

P50

Q35236050-7F88B14E-627E-463F-939B-B879E9318E87

Q35236050-94C29BAF-68B1-4DB1-9ADE-706BD3E35BEE

Q35236050-D1794A60-F202-4BC7-8656-49D62AA980C0

P577

Q35236050-BA55A3EB-51C8-4FF3-9289-06A9E5159140

P5875

Q35236050-001E86A5-CF00-492E-B7AC-4E17AFA20F51

P698

Q35236050-3211DCCE-FA0A-4CB0-8143-428CD72119B5

P932

Q35236050-CBF51F25-DC24-4438-AC6F-8FA22B9C80A3

P356

HAEMATOL.2014.114587

P1433

P1476

Elevated hypercoagulability markers in hemoglobin SC disease

@en

P2093

Fernando F Costa

http://www.w3.org/2001/XMLSchema#string

Joyce M Annichino-Bizzacchi

http://www.w3.org/2001/XMLSchema#string

Marina P Colella

http://www.w3.org/2001/XMLSchema#string

Nicola Conran

http://www.w3.org/2001/XMLSchema#string

Sara T Olalla Saad

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The paradox of hemoglobin SC disease

The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.

Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

Association of coagulation activation with clinical complications in sickle cell disease

The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

Pulmonary embolism in sickle cell disease: a case-control study.

Hemoglobin sickle cell disease complications: a clinical study of 179 cases

Molecular and cellular pathogenesis of hemoglobin SC disease.

P304

466-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2014.114587

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

João Agostinho Machado-Neto

Erich V De Paula

P577

2015-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271022773

http://www.w3.org/2001/XMLSchema#string

P698

25596272

http://www.w3.org/2001/XMLSchema#string

P932

4380719

http://www.w3.org/2001/XMLSchema#string